Stock Under $10 with 50-100% upside potential - 14 Days FREE!

MidCap Financial Enjoys Record 2012

BETHESDA, Md., Jan. 10, 2013 /PRNewswire/ -- MIDCAP FINANCIAL, LLC, the nation's leading independent commercial finance company focused exclusively on middle market healthcare companies, announced today that during 2012, it originated over $990 million in credit commitments to borrowers in its targeted markets.  These commitments comprised 78 new loan facilities among 56 distinct customer relationships spread among MidCap's four healthcare lending focus areas.

This record level of volume brings MidCap's total originated commitments since its 2008 inception to more than $2.58 billion among 225 facilities to 133 distinct customer relationships.

"We are pleased with our 2012 performance," said Howard Widra, MidCap's CEO.  "We were able to capitalize on our unparalleled experience in lending to the middle market healthcare industry by deploying our almost $1.8 billion in capital commitments to address the senior financing needs of our target markets.  The healthcare industry continues to be one of the largest and most important economic sectors in America, and we believe we are very well positioned to achieve another record year in 2013."

About MidCap Financial, LLC:

MidCap Financial is a commercial finance company focused on middle market lending in the broad national healthcare industry.  MidCap specializes in $5 million to $200 million loans. The company is headquartered in Bethesda, MD, with offices in Chicago and Los Angeles, and focuses in four areas:

-Asset-Based working capital loans to healthcare providers collateralized by third-party accounts receivable and other assets;-Leveraged loans to healthcare companies backed by private equity sponsors;-Life Sciences loans to VC-backed and public pharmaceutical, biotech, and medical device companies;-Real Estate loans to skilled nursing facilities, senior housing properties, and medical office buildings

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,387.58 52.30 0.34%
NASDAQ 3,502.12 5.69 0.16%
S&P 500 1,669.16 2.87 0.17%
US 10 Yr 1.944% -0.021

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs